| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-09 00:13:46 UTC |
|---|
| Updated at | 2022-09-09 00:13:46 UTC |
|---|
| NP-MRD ID | NP0276223 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (3r,4r,6ar,6bs,8ar,11r,12s,14bs)-3-(acetyloxy)-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid |
|---|
| Description | Acetyl-11-keto-beta-boswellic acid, also known as acetyl-11-keto-β-boswellate or ackba, belongs to the class of organic compounds known as triterpenoids. These are terpene molecules containing six isoprene units. (3r,4r,6ar,6bs,8ar,11r,12s,14bs)-3-(acetyloxy)-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid is found in Boswellia papyrifera and Boswellia sacra. (3r,4r,6ar,6bs,8ar,11r,12s,14bs)-3-(acetyloxy)-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid was first documented in 2022 (PMID: 35437857). Based on a literature review a significant number of articles have been published on Acetyl-11-keto-beta-boswellic acid (PMID: 35399644) (PMID: 35350335) (PMID: 35306283) (PMID: 36115600) (PMID: 35582102) (PMID: 35918768). |
|---|
| Structure | C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)C2[C@H]1C InChI=1S/C32H48O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23?,24-,25?,26?,28-,29+,30-,31-,32-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Acetyl-11-keto-b-boswellate | Generator | | Acetyl-11-keto-b-boswellic acid | Generator | | Acetyl-11-keto-beta-boswellate | Generator | | Acetyl-11-keto-β-boswellate | Generator | | Acetyl-11-keto-β-boswellic acid | Generator | | AcKBA | MeSH | | AKBA CPD | MeSH | | Acetyl-11-keto-boswellic acid | MeSH | | Acetyl-11-ketoboswellic acid | MeSH | | 3-O-Acetyl-11-keto-boswellic acid | MeSH |
|
|---|
| Chemical Formula | C32H48O5 |
|---|
| Average Mass | 512.7310 Da |
|---|
| Monoisotopic Mass | 512.35017 Da |
|---|
| IUPAC Name | (3R,4R,6aR,6bS,8aR,11R,12S,14bS)-3-(acetyloxy)-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid |
|---|
| Traditional Name | (3R,4R,6aR,6bS,8aR,11R,12S,14bS)-3-(acetyloxy)-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@@H]1CC[C@]2(C)CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@@H](OC(C)=O)[C@@](C)(C5CC[C@@]34C)C(O)=O)C2[C@H]1C |
|---|
| InChI Identifier | InChI=1S/C32H48O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23?,24-,25?,26?,28-,29+,30-,31-,32-/m1/s1 |
|---|
| InChI Key | HMMGKOVEOFBCAU-XUEZKKGGSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as triterpenoids. These are terpene molecules containing six isoprene units. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Triterpenoids |
|---|
| Direct Parent | Triterpenoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Triterpenoid
- 15-hydroxysteroid
- Hydroxysteroid
- Steroid
- Cyclohexenone
- Dicarboxylic acid or derivatives
- Carboxylic acid ester
- Ketone
- Carboxylic acid derivative
- Carboxylic acid
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Bhardwaj P, Kumar M, Dhatwalia SK, Garg ML, Dhawan DK: Protective role of AKBA against benzo(a)pyrene-induced lung carcinogenesis by modulating biotransformation enzymes and oxidative stress. J Biochem Mol Toxicol. 2022 Apr 19:e23072. doi: 10.1002/jbt.23072. [PubMed:35437857 ]
- Taherzadeh D, Baradaran Rahimi V, Amiri H, Ehtiati S, Yahyazadeh R, Hashemy SI, Askari VR: Acetyl-11-Keto-beta-Boswellic Acid (AKBA) Prevents Lipopolysaccharide-Induced Inflammation and Cytotoxicity on H9C2 Cells. Evid Based Complement Alternat Med. 2022 Mar 30;2022:2620710. doi: 10.1155/2022/2620710. eCollection 2022. [PubMed:35399644 ]
- Li C, He Q, Xu Y, Lou H, Fan P: Synthesis of 3-O-Acetyl-11-keto-beta-boswellic Acid (AKBA)-Derived Amides and Their Mitochondria-Targeted Antitumor Activities. ACS Omega. 2022 Mar 7;7(11):9853-9866. doi: 10.1021/acsomega.2c00203. eCollection 2022 Mar 22. [PubMed:35350335 ]
- Nadeem A, Ahmad SF, Al-Harbi NO, Sarawi W, Attia SM, Alanazi WA, Ibrahim KE, Alsanea S, Alqarni SA, Alfardan AS, Bakheet SA: Acetyl-11-keto-beta-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-kappaB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis. Int Immunopharmacol. 2022 Jun;107:108703. doi: 10.1016/j.intimp.2022.108703. Epub 2022 Mar 17. [PubMed:35306283 ]
- Song J, Liao W, Deng X, Zhang D, Lin J, Xu R, Han L: Analysis of the pharmacodynamic difference between Xiaojin Pills taken with Chinese Baijiu and water based on serum pharmacochemistry and pharmacokinetics. J Ethnopharmacol. 2023 Jan 10;300:115723. doi: 10.1016/j.jep.2022.115723. Epub 2022 Sep 14. [PubMed:36115600 ]
- Teng YJ, Deng Z, Ouyang ZG, Zhou Q, Mei S, Fan XX, Wu YR, Long HP, Fang LY, Yin DL, Zhang BY, Guo YM, Zhu WH, Huang Z, Zheng P, Ning DM, Tian XF: Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway. World J Gastrointest Oncol. 2022 Apr 15;14(4):872-886. doi: 10.4251/wjgo.v14.i4.872. [PubMed:35582102 ]
- Li W, Liu J, Fu W, Zheng X, Ren L, Liu S, Wang J, Ji T, Du G: Correction: 3-O-acetyl-11-keto-beta-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. J Exp Clin Cancer Res. 2022 Aug 3;41(1):236. doi: 10.1186/s13046-022-02454-7. [PubMed:35918768 ]
- Yang T, Lin X, Li H, Zhou X, Fan F, Yang J, Luo Y, Liu X: Acetyl-11-Keto-Beta Boswellic Acid (AKBA) Protects Lens Epithelial Cells Against H(2)O(2)-Induced Oxidative Injury and Attenuates Cataract Progression by Activating Keap1/Nrf2/HO-1 Signaling. Front Pharmacol. 2022 Jul 11;13:927871. doi: 10.3389/fphar.2022.927871. eCollection 2022. [PubMed:35899124 ]
- Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S: Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis. Genes (Basel). 2022 Jul 25;13(8):1324. doi: 10.3390/genes13081324. [PubMed:35893061 ]
- Raina D, Khan FG, Tiwari H, Sangwan PL, Nargotra A, Kumar V, Khan IA, Saran S: Boswellic acids, as novel inhibitor targeting peptidoglycan biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) in Escherichia coli. Arch Microbiol. 2022 Jul 12;204(8):472. doi: 10.1007/s00203-022-03066-7. [PubMed:35819545 ]
- Ding Y, Chen M, Wang M, Wang M, Zhang T, Park J, Zhu Y, Guo C, Jia Y, Li Y, Wen A: Author Correction: Neuroprotection by acetyl-11-keto-beta-boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway. Sci Rep. 2022 Jul 7;12(1):11547. doi: 10.1038/s41598-022-15106-9. [PubMed:35798757 ]
- Xie X, Liu Q, Zhu F, Zhang T, Xu X, Tao Y: Tracing analgesic constituents from crude and vinegar-processed resin of Boswellia carterii by integrating ultra-performance liquid chromatography tandem mass spectrometry-based determination, analgesic evaluation in mice, and gray relationship analysis. Biomed Chromatogr. 2022 Sep;36(9):e5430. doi: 10.1002/bmc.5430. Epub 2022 Jul 3. [PubMed:35727297 ]
- Nakano K, Sasaki S, Kataoka T: Bioactive Evaluation of Ursane-Type Pentacyclic Triterpenoids: beta-Boswellic Acid Interferes with the Glycosylation and Transport of Intercellular Adhesion Molecule-1 in Human Lung Adenocarcinoma A549 Cells. Molecules. 2022 May 11;27(10):3073. doi: 10.3390/molecules27103073. [PubMed:35630550 ]
- Orhan C, Tuzcu M, Durmus AS, Sahin N, Ozercan IH, Deeh PBD, Morde A, Bhanuse P, Acharya M, Padigaru M, Sahin K: Protective effect of a novel polyherbal formulation on experimentally induced osteoarthritis in a rat model. Biomed Pharmacother. 2022 Jul;151:113052. doi: 10.1016/j.biopha.2022.113052. Epub 2022 May 17. [PubMed:35588576 ]
- Karlapudi V, Sunkara KB, Konda PR, Sarma KV, Rokkam MP: Efficacy and Safety of Aflapin(R), a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study. J Am Nutr Assoc. 2023 Feb;42(2):159-168. doi: 10.1080/07315724.2021.2014370. Epub 2022 Feb 15. [PubMed:35512759 ]
- LOTUS database [Link]
|
|---|